gensci098
Small moleculeexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Sep 24, 2024 (NCT06569758)
Timeline
2020s
- Jan 1, 2024
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Thyroid stimulating hormone receptorINHIBITOR
TSHR inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07286656 | Phase 1 | Dec 9, 2025 | China Medical University, GeneScience Pharmaceuticals Co., Ltd. |
| NCT06569758 | Phase 1 | Sep 24, 2024 | GeneScience Pharmaceuticals Co., Ltd., Jiao Tong University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| GeneScience Pharmaceuticals Co., Ltd. | For profit | 2 | 2 | 1 | 2024 |
| China Medical University | Academic/Hospital | 1 | 0 | 1 | 2025 |
| Jiao Tong University | Academic/Hospital | 1 | 0 | 1 | 2024 |
3 organizations
Page 1 / 1